Kronos Bio, Inc. (KRON)
NASDAQ: KRON · Real-Time Price · USD
0.970
+0.020 (2.12%)
Jan 2, 2025, 4:00 PM EST - Market closed
Kronos Bio Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Kronos Bio stock have an average target of 1.63, with a low estimate of 1.00 and a high estimate of 2.25. The average target predicts an increase of 68.02% from the current stock price of 0.97.
Analyst Consensus: Buy
* Price targets were last updated on Nov 14, 2024.
Analyst Ratings
The average analyst rating for Kronos Bio stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $6 → $1 | Buy → Hold | Downgrades | $6 → $1 | +3.08% | Nov 14, 2024 |
| TD Cowen | TD Cowen | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 14, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $6 | Buy | Reiterates | $6 | +518.49% | Oct 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $2.25 | Strong Buy | Reiterates | $2.25 | +131.93% | Aug 19, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $2.25 | Strong Buy | Reiterates | $2.25 | +131.93% | Aug 1, 2024 |
Financial Forecast
Revenue This Year
10.20M
from 6.29M
Increased by 62.21%
Revenue Next Year
n/a
from 10.20M
EPS This Year
-1.33
from -1.95
EPS Next Year
-1.33
from -1.33
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 10.5M | n/a | n/a | |||
| Avg | 10.2M | n/a | n/a | |||
| Low | 9.8M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 67.0% | - | - | |||
| Avg | 62.2% | - | - | |||
| Low | 55.9% | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.37 | -1.37 | -1.42 |
| Avg | -1.33 | -1.33 | -1.38 |
| Low | -1.27 | -1.27 | -1.32 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.